Skip to main content
SpringerLink
Log in

New Zealand: Where Have We Been?

  • Chapter
  • First Online:
ICU Resource Allocation in the New Millennium

  • 801 Accesses

Abstract

New Zealand is a small island nation (population ∼4.4 million in 2010) in the south west Pacific, at least 2,000 km from any of its nearest neighbours—Australia and other South Pacific island nations. The population is increasingly ethnically diverse, including ∼15 % who identify as Maori (the indigenous people) and ∼15 % as Asian or Pacific people [1]. New Zealand ranks highly internationally on many measures of quality of life including educational attainment, economic, political and press freedom and lack of corruption. It was ranked third in the world in 2010 (behind Norway and Australia and just ahead of the USA) by the UN Development Programme [2] on the Human Development Index—a composite index of life expectancy, education and income. Per capita GDP at purchasing power parity (PPP) is $27,420 in 2010—or 58 % of US per capita GDP [3]. Total health expenditure per capita at PPP was $2,497 in 2007 [2], around 75 % of that in Australia, Canada and most countries in western Europe but only a third of US health expenditure at PPP in 2007 ($7,285).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. New Zealand Census Data 2006. Statistics New Zealand, Wellington. Available via http://www.stats.govt.nz/. Accessed 16 Nov 2010.

  2. The Real Wealth of Nations: Pathways to Human Development. Human Development Report 2010. United Nations Development Programme, UN Plaza, New York, NY 10017, USA. Available via http://hdr.undp.org/en/. Accessed 16 Nov 2010.

  3. World Economic Outlook database. October 2010. International Monetary Fund. Washington DC 20431, USA. Available at http://www.imf.org/external/pubs/ft/weo/2010/02/weodata/index.aspx. Accessed 16 Nov 2010.

  4. Davis P, Lay-Yee R, Fitzjohn J, Hider P, Briant R, Schug S. Compensation for medical injury in New Zealand: does “no-fault” increase the level of claims making and reduce social and clinical selectivity? J Health Polit Policy Law. 2002;27(5):833–54.

    Article  PubMed  Google Scholar 

  5. The New Zealand Health and Disability System: Organisations and Responsibilities. Briefing to the Minister of Health. Ministry of Health, Wellington; 2008. Available at http://www.moh.govt.nz/moh.nsf/pagesmh/8704/$File/nz-health-disability-system-briefing2008.doc. Accessed 16 Nov 2010.

  6. Schoen C, Doty MM. Inequities in access to medical care in five countries: findings from the 2001 Commonwealth Fund International Health Policy Survey. Health Policy. 2004;67(3): 309–22.

    Article  PubMed  Google Scholar 

  7. Health Funds Association of New Zealand. Fact File - Health Insurance in New Zealand, October 2010. Available at http://www.healthfunds.org.nz/. Accessed 23 Nov 2010.

  8. Trubuhovich RV. August 26th 1952 at Copenhagen: ‘Bjørn Ibsen’s Day’; a significant event for Anaesthesia. Acta Anaesthesiol Scand. 2004;48(3):272–7.

    Article  PubMed  CAS  Google Scholar 

  9. Trubuhovich RV. On the very first, successful, long-term, large-scale use of IPPV. Albert Bower and V Ray Bennett: Los Angeles, 1948–1949. Crit Care Resusc. 2007;9(1):91–100.

    PubMed  Google Scholar 

  10. Christie C, Bowden TM, Mackenzie IR, Naismith J, Bryant J. Massive doses of adrenaline in acute toxic peripheral circulatory collapse. Lancet. 1947;250:206–7.

    Article  Google Scholar 

  11. Poland A. Guy’s Hospital. Scalded glottis; tracheotomy; artificial respiration for five hours and a half; recovery. Lancet. 1850;55:670–1.

    Article  Google Scholar 

  12. Spence M. The emergency treatment of acute respiratory failure. Anesthesiology. 1962;23: 524–37.

    Article  PubMed  CAS  Google Scholar 

  13. Spence M. A regime for the treatment of tetanus. N Z Med J. 1961; 325–34.

    Google Scholar 

  14. Irvine RO, Montgomerie MB, Spence M. Assisted respiration, noradrenaline infusion and the artificial kidney for glutethimide (“Doriden”) poisoning. Med J Aust. 1963;2:277–9.

    PubMed  CAS  Google Scholar 

  15. Campion DS, Spence M. Barbiturate intoxication occurring in Auckland. N Z Med J. 1964;63:206–10.

    PubMed  CAS  Google Scholar 

  16. Spence M. An organization for intensive care. Med J Aust. 1967;1(16):795–801.

    PubMed  CAS  Google Scholar 

  17. The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med. 2007;357(9):874–84.

    Article  Google Scholar 

  18. Myburgh JA, Cooper DJ, Finfer SR, Venkatesh B, Jones D, Higgins A, Bishop N, Higlett T, The Australasian Traumatic Brain Injury Study (ATBIS) Investigators for the ANZICS Clinical Trials Group. Epidemiology and 12-month outcomes from traumatic brain injury in Australia and New Zealand. J Trauma. 2008;64(4):854–62.

    Article  PubMed  Google Scholar 

  19. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, Du B, McArthur C, Myburgh J, The SAFE TRIPS Investigators. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14:R185. Available at http://ccforum.com/content/14/5/R185.

    Article  PubMed  Google Scholar 

  20. The SAFE Study Investigators. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med. 2011;37(1):86–96. Epub October 2010.

    Article  Google Scholar 

  21. The Blood Observational Study Investigators on behalf of the ANZICS-Clinical Trials Group. Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med. 2010;36(7):1138–46.

    Article  Google Scholar 

  22. Robertson MS, Nichol AD, Higgins AM, Bailey MJ, Presneill JJ, Cooper DJ, Webb SA, McArthur C, MacIsaac CM, The VTE Point Prevalence Investigators for the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) and the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS CTG). Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units. Crit Care Resusc. 2010;12(1):9–15.

    PubMed  Google Scholar 

  23. Flabouris A, Chen J, Hillman K, Bellomo R, Finfer S, The MERIT Study investigators from the Simpson Centre and the ANZICs Clinical Trials Group. Timing and interventions of emergency teams during the MERIT study. Resuscitation. 2010;81(1):25–30.

    Article  PubMed  Google Scholar 

  24. Bellomo R, Morimatsu H, Presneill J, French C, Cole L, Story D, Uchino S, Naka T, Finfer S, Cooper DJ, Myburgh J, on behalf of the SAFE Study Investigators and the Australian and New Zealand Intensive Care Society Clinical Trials Group. Effects of saline or albumin resuscitation on standard coagulation tests. Crit Care Resusc. 2009;11:250–6.

    PubMed  Google Scholar 

  25. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361(20):1925–34.

    Article  Google Scholar 

  26. The RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-­replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627–38.

    Article  Google Scholar 

  27. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.

    Article  PubMed  Google Scholar 

  28. Chen J, Bellomo R, Flabouris A, Hillman K, Finfer S, MERIT Study Investigators for the Simpson Centre; ANZICS Clinical Trials Group. The relationship between early emergency team calls and serious adverse events. Crit Care Med. 2009;37(1):148–53.

    Article  PubMed  Google Scholar 

  29. Peake SL, Bailey M, Bellomo R, Cameron PA, Cross A, Delaney A, Finfer S, Higgins A, Jones DA, Myburgh JA, Syres GA, Webb SA, Williams P, ARISE Investigators for the Australian and New Zealand Intensive Care Society Clinical Trials Group. Australasian resuscitation of sepsis evaluation (ARISE): a multi-centre, prospective, inception cohort study. Resuscitation. 2009;80(7):811–8. Epub 2009 May 20.

    Article  PubMed  Google Scholar 

  30. Doig GS, Simpson F, Finfer S, Delaney A, Davies AR, Mitchell I, Dobb G. Nutrition Guidelines Investigators of the ANZICS Clinical Trials Group. Effect of evidence-based feeding guidelines on mortality of critically ill adults: a cluster randomized controlled trial. JAMA. 2008;300(23):2731–41.

    Article  PubMed  CAS  Google Scholar 

  31. Bellomo R, Chapman M, Finfer S, Hickling K, Myburgh J. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet. 2000;356(9248): 2139–43.

    Article  PubMed  CAS  Google Scholar 

  32. Young PJ, Arnold R. Intensive care triage in Australia and New Zealand. N Z Med J. 2010;123(1316):33–46.

    PubMed  Google Scholar 

  33. Streat SJ, Judson JA. Cost containment: the Pacific. New Zealand. New Horiz. 1994;2(3): 392–403.

    PubMed  CAS  Google Scholar 

  34. Streat S. When do we stop? Crit Care Resusc. 2005;7:227–32.

    Google Scholar 

  35. Faunce T. Emerging roles for law and human rights in ethical conflicts surrounding neuro critical care. Crit Care Resusc. 2005;7(3):221–7.

    Google Scholar 

  36. Faunce TA. Reference pricing for pharmaceuticals: is the Australia-United States Free Trade Agreement affecting Australia’s Pharmaceutical Benefits Scheme? Med J Aust. 2007;187(4):240–2. Epub 2007 Jun 13.

    PubMed  Google Scholar 

  37. Zimmerman JE, Knaus WA, Judson JA, Havill JH, Trubuhovich RV, Draper EA, Wagner DP. Patient selection for intensive care: a comparison of New Zealand and United States hospitals. Crit Care Med. 1988;16(4):318–26.

    Article  PubMed  CAS  Google Scholar 

  38. Bagshaw SM, Webb SA, Delaney A, George C, Pilcher D, Hart GK, Bellomo R. Very old patients admitted to intensive care in Australia and New Zealand: a multi-centre cohort analysis. Crit Care. 2009;13(2):R45.

    Article  PubMed  Google Scholar 

  39. Drennan K, Hart GK, Hicks P. Intensive care resources and activity: Australia and New Zealand 2006/2007. ANZICS, Melbourne. 2008 Available at http://www.anzics.com.au/. Accessed 23 Nov 2010.

  40. Wunsch H, Angus DC, Harrison DA, Collange O, Fowler R, Hoste EA, de Keizer NF, Kersten A, Linde-Zwirble WT, Sandiumenge A, Rowan KM. Variation in critical care services across North America and Western Europe. Crit Care Med. 2008;36(10):2787–93.

    Article  PubMed  Google Scholar 

  41. Streat SJ. Illness trajectories are also valuable in critical care (letter). BMJ. 2005;330(7502): 1272.

    Article  PubMed  Google Scholar 

  42. Ho KM, Liang J, Hughes T, O’Connor K, Faulke D. Withholding and withdrawal of therapy in patients with acute renal injury: a retrospective cohort study. Anaesth Intensive Care. 2003;31(5):509–13.

    PubMed  CAS  Google Scholar 

  43. Ho KM, Liang J. Withholding and withdrawal of therapy in New Zealand intensive care units (ICUs): a survey of clinical directors. Anaesth Intensive Care. 2004;32(6):781–6.

    PubMed  CAS  Google Scholar 

  44. Cuthbertson SJ, Margetts MA, Streat SJ. Bereavement follow-up after critical illness. Crit Care Med. 2000;28(4):1196–201.

    Article  PubMed  CAS  Google Scholar 

  45. Cassell J, Buchman TG, Streat S, Stewart RM. Surgeons, Intensivists and the covenant of care – administrative models and values affecting care at the end of life - Updated. Crit Care Med. 2003;31(5):1551–9.

    Article  PubMed  Google Scholar 

  46. Cassell J. Life and death in intensive care. Philadelphia, PA: Temple University Press; 2005.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Critical Care Medicine, Auckland City Hospital, 2 Park Road, Grafton, Auckland, 1023, New Zealand

    Stephen Streat B.Sc., M.B., Ch.B., F.R.A.C.P.

Authors
  1. Stephen Streat B.Sc., M.B., Ch.B., F.R.A.C.P.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen Streat B.Sc., M.B., Ch.B., F.R.A.C.P. .

Editor information

Editors and Affiliations

  1. and Neurological Surgery, University of Pittsburgh, Departments of Critical Care Medicine, School of Medicine, Pittsburgh, 15219, Pennsylvania, USA

    David W. Crippen

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Streat, S. (2013). New Zealand: Where Have We Been?. In: Crippen, D. (eds) ICU Resource Allocation in the New Millennium. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3866-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-3866-3_9

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-3865-6

  • Online ISBN: 978-1-4614-3866-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation